First Citizens Bank & Trust’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,792
Closed -$286K 396
2022
Q1
$286K Sell
3,792
-1,269
-25% -$86.7K 0.01% 323
2021
Q4
$378K Sell
5,061
-456
-8% -$27K 0.01% 260
2021
Q3
$260K Sell
5,517
-69
-1% -$3K 0.01% 332
2021
Q2
$226K Buy
5,586
+30
+0.5% +$1.24K 0.01% 372
2021
Q1
$228K Buy
+5,556
New +$207K 0.01% 358
2020
Q3
Sell
-8,518
Closed -$237K 373
2020
Q2
$237K Buy
+8,518
New +$208K 0.02% 310

Other funds holding ACLS

First Citizens Bank & Trust's ACLS Position: Q2 2022 in Review

First Citizens Bank & Trust sold out of Axcelis (ACLS) in Q2 2022, closing a stake of 3,792 shares — an estimated $286K sold.

First Citizens Bank & Trust first reported a position in ACLS in Q2 2020 and held it in 6 quarters. The position peaked at $378K in Q4 2021. 276 funds tracked by Wall St. Rank hold ACLS as of Q2 2022.

  • First Citizens Bank & Trust reported no remaining Axcelis position as of Q2 2022 after selling out during the quarter.
  • First Citizens Bank & Trust sold 3,792 Axcelis shares in Q2 2022, an estimated $286K.
  • First Citizens Bank & Trust first reported a position in Axcelis in Q2 2020 and held it in 6 quarters.
  • First Citizens Bank & Trust's Axcelis position peaked at $378K in Q4 2021.
  • 276 funds tracked by Wall St. Rank held Axcelis as of Q2 2022.

Based on First Citizens Bank & Trust's 13F filing for Q2 2022, filed 26 Jul 2022.